297 results on '"Michalová, K."'
Search Results
2. Near-tetraploid acute myeloid leukemias: an EGIL retrospective study of 25 cases
3. Real-time quantitative PCR detection of WT1 gene expression in children with AML: prognostic significance, correlation with disease status and residual disease detection by flow cytometry
4. Smad5, a tumor suppressor candidate at 5q31.1, is hemizygously lost and not mutated in the retained allele in human leukemia cell line HL60
5. Agammaglobulinaemia in a girl with a mosaic of ring 18 chromosome
6. P047 Determining of intensity methylation in the area of promoter gene P15INK4B as prognostic marker in patients with myelodysplastic syndromes (MDS)
7. P026 A limited benefit of isolated 5q deletion on prognosis – results of a long term retrospective analysis
8. C011 Gene methylation, telomere length and activity of telomerase reflect the disease activity in MDS patients and may help to assess an individual risk of patients
9. C010 Differentially expressed genes of CD34+ between patients with early and advanced myelodysplastic syndrome
10. Occurrence of penile intraepithelial neoplasia in histological samples from circumcisions
11. 18-FDG PET-MRI in diagnostics of penile cancer, first experience
12. ESTABLISHED CELL LINES AND PATIENT-DERIVED XENOGRAFTS REPRESENT EQUALLY RELEVANT MODELS OF AGGRESSIVE LYMPHOMAS
13. Zvířecí modely jaterních onemocnění a jejich využití v experimentální chirurgii.
14. A new case of chronic myeloid leukemia (CML) in myeloid blast crisis with an atypical (b3/a3) junction of the BCR/ABL gene
15. The occurrence of T-cell malignancies in patients treated by chemotherapy for acute myeloid leukemia
16. Separation of replication and transcription domains in nucleoli
17. 112 - 18-FDG PET-MRI in diagnostics of penile cancer, first experience
18. 228 - MDS Patients with Del(5Q) and Trisomy 8 in Two Independent Clones Have High fli-1 and Cereblon Messenger RNA Levels
19. 227 - High Level of Full-Length Cereblon Messenger RNA and Protein is Important for Lenalidomide Efficacy in Lower Risk MDS Patients
20. 191 - Lenalidomide Treatment in Lower Risk MDS – The Experience of One Czech Center (Positive Effect of Erythropoietin ± Prednisone Addition)
21. 90 - Cytogenetic Clonal Evolution in Myelodysplastic Syndromes (MDS) with Isolated Del(5Q)
22. Využití molekulárně cytogenetických technik při analýze chromozomových aberací u hematologických malignit.
23. Dicentric Yp chromosome in a patient with the gonadal dysgenesis and gonadoblastoma
24. Hereditary haemochromatosis caused by homozygousHJVmutation evolved through paternal disomy
25. Cytogenetic features of acute lymphoblastic and myeloid leukemias in pediatric patients with Down syndrome: An iBFM-SG study
26. The effect of allogeneic stem cell transplantation on high risk chronic lymphocytic leukaemia: a single centre retrospective analysis
27. 170 MECHANISM OF FORMATION OF COMPLEX CHROMOSOMAL ABERRATIONS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS): CLONAL EVOLUTION OR CHROMOTHRIPSIS?
28. 106 PATIENTS WITH TWO UNRELATED CLONES DEL(5Q) AND TRISOMY 8 – A SUBTYPE OF 5Q- SYNDOME? UNCERTAIN PROGNOSIS OF PATIENTS WITH DECREASED DEL(5Q) CLONE DUE TO LENALIDOMIDE
29. 49 THE PROGNOSTIC SIGNIFICANCE OF TP53 MUTATIONS IN MDS PATIENTS WITH DEL(5Q)
30. 42 THE EFFICACY OF LENALIDOMIDE IN LOWER RISK MYELODYSPLASTIC SYNDROME WITH ISOLATED 5Q DELETION IS DEPENDENT ON HIGH LEVEL OF FULL-LENGTH CEREBLON MESSENGER RNA
31. O35 A prognostic impact of transfusion dependency on survival of patients with early myelodysplastic syndrome
32. O51 Acute myeloid leukemia in the Czech Republic and the Slovak Republic from 1996 to 2007. Prognostic and therapeutic results of 1890 patients from the ALERT registry
33. Získaná uniparentální disomie v buňkách kostní dřeně nemocných s myelodysplastickými syndromy a komplexním karyotypem.
34. Silent ischemia in asymptomatic patients with diabetes mellitus 2. Type and another risk factors
35. Location of the BCR/ABL Fusion Genes on Both Chromosomes 9q34 in Ph Negative Chronic Myeloid Leukemia
36. Molekulárně cytogenetická analýza chromozomových aberací v buňkách nízkostupňových gliomů a její přínos pro klasifi kaci nádoru.
37. Jsme oprávněni řadit nemocné s dvěma samostatnými buněčnými klony a to s delecí 5q a s trizomií 8 jako podskupinu myelodysplastického syndromu typu 5q- syndromu?
38. No Evidence for MLL/AF4 Expression in Normal Cord Blood Samples
39. P-231 The role of Fli1 and p53 for the effective megakaryopoiesis in 5q-syndrome
40. P-220 A comparison of effect of stem cell transplantation (SCT) with different treatment approaches on long term survival of MDS patients
41. Derivative (6)t(1;6)(q22;p21) revealed in bone marrow cells by FISH 9 months before diagnosis of acute T-lymphoblastic leukemia
42. P 181 Immunosuppressive effect of bovine spermal ribonuclease in animal keratoplasty models
43. Secondary myelodysplastic syndrome following myeloma therapy
44. Mixed myelodysplastic and myeloproliferative syndromes
45. Karyotype at diagnosis, subsequent leukemic transformation and survival in MDS
46. Partial trisomy of 3q detected by chromosome painting in a case of juvenile chronic myelomonocytic leukemia
47. Cytogenetic study of MDS evolving to AML
48. 301 Thrombocytopenia at diagnosis as an important negative prognostic marker in isolated 5q- MDS (IPSS low and Intermediate-1)
49. 274 The response of FLi1, EKLF, TP53 (p53), PU.1, MDM2 gene expression in 5q- syndrome to lenalidomide treatment
50. 264 Genomic imbalances in 73 patients with MDS and complex karyotypes
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.